Cargando…
Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
Autores principales: | Patel, JM, Snaith, C, Thickett, D, Linhortova, L, Melody, T, Hawkey, P, Barnett, T, Jones, A, Hong, T, Perkins, G, Cooke, M, Gao-Smith, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066942/ http://dx.doi.org/10.1186/cc9688 |
Ejemplares similares
-
Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)
por: Patel, Jaimin M, et al.
Publicado: (2012) -
Sepsis and Asepsis
por: Kacker, R. K.
Publicado: (1907) -
Asepsis
por: Hallilay, H.
Publicado: (1925) -
Physiological-dose steroid therapy in sepsis [ISRCTN36253388]
por: Yildiz, Orhan, et al.
Publicado: (2002) -
Asepsis and Antiseptics
Publicado: (1909)